AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)

NCT07555730 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Overweight or Obesity; Type 2 Diabetes
Weight Loss Maintenance

Interventions

BEHAVIORAL: AI assisted multi-domain lifestyle intervention
DRUG: Tirzepatide

Sponsor

Huazhong University of Science and Technology